Highlights Strides Pharma Science Limited

Equities

STAR

INE939A01011

Market Closed - NSE India S.E. Other stock markets 07:43:50 2024-05-10 am EDT			5-day change	1st Jan Change
843 ^INR	+1.17%		-4.91%	+29.85%

May. 10	Market Heavyweights Lifts Indian Equities to End Week Higher	MT
May. 10	Strides Pharma Arm Gets US FDA's Approval for Generic Drug for Hypocalcemia	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Market Heavyweights Lifts Indian Equities to End Week Higher	May. 10	MT
Strides Pharma Science Gets US FDA Nod for Fluoxetine Tabs	Apr. 09	MT
Strides Pharma Science Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Jan. 30	CI
Strides Pharma Science Arm Gets US FDA Nod for Pregabalin Capsules	Jan. 25	MT
Strides Pharma Science's Swiss Unit to Sell Entire Stake in Eris Pharma	Jan. 11	MT
Strides Pharma Science Arm Acquires Additional 25% Stake in Neviton Softech	Jan. 08	MT
Strides Pharma Science Acquires Minority Stake in Two Renewable Energy Companies	Jan. 02	MT
Amneal Expands Portfolio with Addition of Icosapent Ethyl Acid Soft Gel Capsules	Dec. 01	CI
Strides Pharma Unit Gets US FDA Approval for Generic Bowel Prep Kit Solution	Nov. 22	MT
Strides Pharma Global Pte. Limited Receives USFDA Approval for Generic Suprep®? Bowel Prep Kit	Nov. 22	CI
Strides Pharma Science Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	23-10-30	CI
Strides Pharma Science to Sell Singapore Manufacturing Site for $15 Million	23-10-30	MT
Strides Pharma Arm Gets US FDA Nod for HIV Treatment Drug	23-10-04	MT
Strides Pharma Global Pte. Limited Receives USFDA Approval for Efavirenz, Emtricitabine & Tenofovir Disoproxil Fumurate Tablets	23-10-04	CI
India's Strides Pharma to spin off contract development unit	23-09-25	RE
Strides Pharma Science Arm Gets US FDA Nod for Icosapent Ethyl Capsules	23-09-24	MT
Strides Pharma Global Pte. Limited Receives Tentative United States Food & Drug Administration Approval for Dolutegravir Tablets	23-09-14	CI
Strides Pharma Science Arm Gets US FDA Nod for Sevelamer Carbonate for Oral Suspension	23-09-10	MT
Strides Pharma Global Pte. Limited Receives Usfda Approval for Sevelamer Carbonate for Oral Suspension	23-09-09	CI
Strides Pharma Science to Take 100% Stake in Step-Down Subsidiary	23-09-07	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Strides Pharma Science Limited

Equities

STAR

INE939A01011

Highlights

Filters